Floating Button
Home Views Investing ideas

Vaccine rollouts create valuation gaps for investors

Irene Goh
Irene Goh • 5 min read
Vaccine rollouts create valuation gaps for investors
Investors should seize on valuation gaps ahead of market pricing given the successful rollout of Covid-19 vaccines, says Aberdeen,
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The timing of a sustainable rebound in global economic growth hangs on the successful rollout of coronavirus vaccines — opening a window for investors to seize on valuation gaps ahead of market pricing.

We predict the global economy will pick up in the second quarter of 2021, but not rebound until the second half as the approval, production and distribution of vaccines will take time.

The more inoculations that come online, the faster the process of growth normalisation will be. Still, authorities may need to bridge delays in vaccine rollouts with adequate monetary and fiscal support.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.